Blood-based Vienna 3P/5P risk models accurately predict first hepatic decompensation in compensated advanced chronic liver disease

Background & Aims: Invasive measurement of hepatic venous pressure gradient (HVPG) is the gold standard for diagnosing clinically significant portal hypertension (CSPH, i.e. HVPG ≥10 mmHg), which indicates an increased risk of decompensation. We evaluated the blood-based Vienna 3P/5P models for...

Полное описание

Библиографические подробности

Главные авторы:	Georg Kramer, Benedikt Simbrunner, Mathias Jachs, Lorenz Balcar, Benedikt Silvester Hofer, Nina Dominik, Lukas Hartl, Michael Schwarz, Georg Semmler, Christian Sebesta, Paul Thöne, Sophia Geisselbrecht, Benjamin Maasoumy, Eduardo Alvarez, Martin Sebastian McCoy, Oleksandr Petrenko, Jiří Reiniš, Philipp Schwabl, Albert F. Stättermayer, Michael Trauner, Mattias Mandorfer, Thomas Reiberger
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Elsevier 2026-02-01
Серии:	JHEP Reports
Предметы:	Cirrhosis Baveno clinically significant portal hypertension non-invasive tests machine learning betablockers
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S2589555925003246
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!